Workflow
2 Penny stocks to buy in May 2025
BLDEBlade(BLDE) Finbold·2025-04-27 13:17

Market Overview - The stock market is showing positive momentum as April closes, driven by hopes of easing trade tensions between China and the U.S. [1] - May presents a fresh opportunity for investors, particularly in penny stocks, as optimism around trade tariff resolutions builds [2][6] Company Analysis: Compass Therapeutics (NASDAQ: CMPX) - Compass Therapeutics has demonstrated strong stock performance in 2025, with a year-to-date increase of over 38%, currently trading at 1.94[3][5]Thecompanyisadvancingitsclinicalpipeline,particularlywithCTX10726,aPD1xVEGFAbispecificantibody,andplanstosubmitanINDbytheendof2025[5][7]AnalystspredictasignificantupsideforCMPX,withaconsensus"Buy"ratingandanaveragepricetargetof1.94 [3][5] - The company is advancing its clinical pipeline, particularly with CTX-10726, a PD-1 x VEGF-A bispecific antibody, and plans to submit an IND by the end of 2025 [5][7] - Analysts predict a significant upside for CMPX, with a consensus "Buy" rating and an average price target of 12, indicating a potential increase of 527% over the next year [7] Company Analysis: Blade Air Mobility (NASDAQ: BLDE) - Blade Air Mobility operates a technology-enabled air transport platform, focusing on medical and passenger transportation, with expected double-digit growth in its medical business in 2025 [8] - The company has strengthened its financial position, achieving positive cash flow and maintaining a debt-free balance sheet with 136millionincash,allowingforfleetgrowthandpotentialsharebuybacks[9]Despitearecentrallyofover4136 million in cash, allowing for fleet growth and potential share buybacks [9] - Despite a recent rally of over 4% to 2.71, BLDE is down over 36% year-to-date, but analysts remain optimistic, forecasting a 117% upside with an average price target of $5.83 [9][11]